| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |